#Single-Photon Emission Computed Tomography (SPECT) Systems Market Size

[pharmaceuticals88]

Single-Photon Emission Computed Tomography (SPECT) Systems Market Growing Trends and Demands Analysis forecast 2022 to 2029

The Single-Photon Emission Computed Tomography (SPECT) Systems Market Market Size At USD 3.2 Billion by 2029, exhibiting a CAGR of 5% during 2022-2029

Single-Photon Emission Computed Tomography (SPECT) Systems Market Overview

The Single-Photon Emission Computed Tomography (SPECT) Systems Market report is a comprehensive overview of the market, including a review of its major segments. Alliances are developed after thorough primary and secondary studies. By speaking with industry experts and collecting their data, in-depth market data is produced. The report provides a thorough account of many market factors, including trends, segmentation, growth prospects, chances, difficulties, and competitive analyses.

Get a Sample copy of the report:

List of Key Players Of Single-Photon Emission Computed Tomography (SPECT) Systems Market Report:

GE Healthcare, Guerbet, Lantheus Medical Imaging, Daiichi Sankyo, Eli Lillyand Company, Bayer, Gamma Medica-Ideas Inc, Siemens Healthineers, Philips Healthcare, Toshiba Medical Systems Corporation, Neusoft Medical Systems,

Key Segments Covered in Single-Photon Emission Computed Tomography (SPECT) Systems Market

By Type, it is segmented into

Hybrid SPECT System

Standalone SPECT System

By Application, it is segmented into

Diagnostic Laboratories

Research Institutes

Hospitals

Others

Competitive Landscape

Single-Photon Emission Computed Tomography (SPECT) Systems Market are showing an increasing amount of interest in creating unique products. In addition, several companies are collaborating, merging, and acquiring one another. In the upcoming years, all of these initiatives are anticipated to drive the global Single-Photon Emission Computed Tomography (SPECT) Systems Market to new heights.

The Single-Photon Emission Computed Tomography (SPECT) Systems Market Regional Analysis Covers

– North America: United States, Canada, and Mexico. – South & Central America: Argentina, Chile, and Brazil. – Middle East & Africa: Saudi Arabia, UAE, Turkey, Egypt and South Africa. – Europe: UK, France, Italy, Germany, Spain, and Russia. – Asia-Pacific: India, China, Japan, South Korea, Indonesia, Singapore, and Australia.

Get in Touch with Us: - Phone No.+1 (704) 266-3234

Mail to: Contact@pharmaresearchconsulting.com

[credenceresearchdotblog]

The In Vivo Imaging Market is projected to grow from USD 2915 million in 2024 to an estimated USD 3880.233 million by 2032, with a compound annual growth rate (CAGR) of 3.64% from 2024 to 2032.The in vivo imaging market is a dynamic and rapidly expanding sector in the healthcare industry, playing a pivotal role in preclinical and clinical research. In vivo imaging refers to the visualization of biological processes and structures within a living organism. This technology is instrumental in understanding disease progression, evaluating therapeutic efficacy, and accelerating drug development. The demand for non-invasive, high-resolution, and real-time imaging solutions is propelling the growth of this market across the globe. This article explores the key drivers, technologies, and trends shaping the in vivo imaging market.

Browse the full report at https://www.credenceresearch.com/report/in-vivo-imaging-market

Key Market Drivers

1. Growing Preclinical Research and Drug Development: In vivo imaging techniques have become a cornerstone in preclinical research, particularly in the pharmaceutical and biotechnology sectors. As the demand for new drug development and personalized medicine increases, researchers rely on imaging technologies to visualize the biological effects of therapeutic candidates in real-time. This accelerates the drug development pipeline by providing critical data on safety, efficacy, and pharmacokinetics.

2. Advances in Molecular Imaging: Molecular imaging technologies, such as positron emission tomography (PET), single-photon emission computed tomography (SPECT), and optical imaging, are increasingly being used to study biological pathways at the molecular and cellular levels. These advancements enable researchers to detect diseases earlier, monitor treatment responses, and even predict outcomes in preclinical models. The precision offered by these tools has further driven their adoption in research institutions and pharmaceutical companies.

3. Rising Prevalence of Chronic Diseases: The increasing global incidence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders has underscored the need for effective diagnostic and therapeutic monitoring tools. In vivo imaging systems are critical in detecting tumors, assessing cardiovascular health, and tracking neurological changes in conditions like Alzheimer's and Parkinson's disease. This surge in chronic diseases directly boosts the demand for advanced imaging solutions.

4. Technological Innovations: Significant strides in imaging technologies have been made in recent years. Innovations such as hybrid imaging systems (e.g., PET-CT and PET-MRI), which combine different imaging modalities, have enhanced image resolution, accuracy, and functional data acquisition. These technologies offer a more comprehensive understanding of biological processes, helping clinicians make better-informed decisions.

5. Increased Government and Private Funding: Government and private sector investments in healthcare research and innovation are providing significant financial support to the in vivo imaging market. Research initiatives focusing on cancer, cardiovascular diseases, and other critical health concerns are leading to increased utilization of advanced imaging technologies.

Types of In Vivo Imaging Technologies

1. Magnetic Resonance Imaging (MRI): MRI is one of the most commonly used in vivo imaging techniques due to its ability to generate high-resolution images of soft tissues. It is particularly useful in neurology and cardiology research for imaging the brain, heart, and vascular structures.

2. Positron Emission Tomography (PET): PET imaging is crucial for studying metabolic processes and is widely used in cancer research and neurology. It allows for the real-time assessment of cellular and molecular activity, providing valuable data on tumor metabolism and brain function.

3. Optical Imaging: Optical imaging techniques such as bioluminescence and fluorescence imaging are extensively used in preclinical studies. These non-invasive methods are ideal for monitoring gene expression, protein-protein interactions, and tracking disease progression in animal models.

4. Computed Tomography (CT): CT scanning provides detailed cross-sectional images of bones, organs, and tissues, making it an important tool for studying skeletal structures, lung diseases, and cardiovascular conditions in animal models.

5. Ultrasound Imaging: Ultrasound is widely used in cardiovascular and obstetric research for real-time imaging of blood flow, heart function, and fetal development. It is favored for its non-invasive nature and cost-effectiveness.

Challenges Facing the In Vivo Imaging Market

Despite its rapid growth, the in vivo imaging market faces several challenges. High costs associated with advanced imaging systems, the need for specialized training to operate complex technologies, and ethical concerns regarding animal research are some of the major hurdles. Additionally, integrating these imaging technologies into clinical practice remains a significant challenge, particularly in low-resource settings where access to advanced equipment is limited.

Market Trends and Future Outlook

The future of the in vivo imaging market is promising, with several key trends emerging:

1. Artificial Intelligence (AI) Integration: AI-powered imaging systems are becoming increasingly popular for automating image analysis and improving diagnostic accuracy. Machine learning algorithms are enabling researchers to extract more information from imaging data, leading to better predictive models and personalized treatment plans.

2. Expansion of Optical and Hybrid Imaging: The integration of optical imaging with other modalities like MRI and PET is expected to continue, offering improved sensitivity and resolution for preclinical research. This trend is likely to expand the applications of imaging technologies beyond oncology and neurology into fields like immunology and infectious diseases.

3. Increased Adoption of Imaging in Drug Development: As pharmaceutical companies continue to adopt imaging for drug discovery and development, the market is poised to see increased demand. Imaging will play an increasingly important role in evaluating drug safety and efficacy, reducing the time and cost associated with clinical trials.

Key Player Analysis:

Aspect Imaging Ltd. (Israel)

Biospace Lab (France)

Bruker (U.S.)

CMR Naviscan (U.S.)

FUJIFILM Holdings America Corporation (Canada)

General Electric (U.S.)

Guerbet (France)

Hitachi, Ltd. (Japan)

Koninklijke Philips N.V (Netherlands)

LI-COR, Inc. (U.S.)

Mediso Ltd. (U.S.)

MILabs B.V. (Netherlands)

Miltenyi Biotec (Germany)

MR Solutions (U.K.)

PerkinElmer Inc. (U.S.)

SCANCO Medical AG (Switzerland)

Siemens (Germany)

Takara Bio Inc. (Japan)

Trifoil Imaging (U.S.)

Segmentation:

By Modality:

Optical imaging,

Nuclear imaging,

Magnetic resonance imaging (MRI),

Ultrasound,

Others

By Reagents:

Bioluminescent and fluorescent labels,

Radioisotopes,

Nanoparticles,

Others

By Technique:

Radiography,

Optical imaging,

Magnetic resonance imaging,

Others

 By End User:

Hospitals and clinics,

Research institutions,

Pharmaceutical and biotechnology companies,

Others

By Region

North America

The U.S

Canada

Mexico

Europe

Germany

France

The U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/in-vivo-imaging-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[organicbusinessconsulting]

Global Imaging Workstations Market Size, Share and Demand Forecast 2031

The Global Imaging Workstations Market size was estimated at USD xx billion in 2021 and is expected to hit around USD xx billion by 2030, poised to grow at a compound annual growth rate (CAGR) of xx % from 2022 to 2030.

The term “Imaging Workstations” describes the secondary market for the market for computer-based systems that are used for the processing, analysis, and visualization of medical images. These workstations are used by healthcare professionals, including radiologists, to view and interpret various medical images, such as X-rays, CT scans, MRIs, and ultrasound images. Imaging workstations allow medical professionals to manipulate and enhance images to help diagnose and treat various medical conditions. The market for imaging workstations includes both hardware and software components and encompasses a variety of applications and use cases, including diagnostic imaging, clinical review, and research. The market is driven by technological advancements in medical imaging, an increasing prevalence of chronic diseases, and the growing demand for accurate and timely diagnosis.

The development of advanced imaging technologies and software solutions is one of the primary drivers of the imaging workstations market. Advancements in artificial intelligence (AI) and machine learning (ML) are allowing healthcare professionals to analyze and interpret medical images with greater accuracy and speed, thereby improving patient outcomes. The increasing prevalence of chronic diseases such as cancer, heart disease, and respiratory conditions is driving the demand for medical imaging services. As a result, healthcare providers are investing in imaging workstations to help diagnose and treat these conditions.

Download Free Sample Report

The growth of telemedicine is another key driver of the imaging workstations market. With telemedicine, medical professionals can remotely access and interpret medical images, allowing for faster diagnosis and treatment. Governments around the world are investing in healthcare infrastructure and technology to improve patient outcomes and reduce healthcare costs. This is driving the adoption of imaging workstations in both developed and developing countries. As healthcare spending continues to rise globally, healthcare providers are investing in advanced technologies, including imaging workstations, to improve patient care and outcomes.

The global imaging workstations market is highly competitive and fragmented, with the presence of several large and small players. The key players in the market are focusing on product innovation, strategic partnerships, mergers and acquisitions, and geographical expansion to maintain their market share and increase their customer base.

The competition in the market is primarily driven by technological advancements, product innovation, and pricing strategies. The players are constantly investing in research and development to improve their product offerings and stay ahead of the competition. They are also focused on providing customized solutions to meet the specific needs of their customers.

Market Segmentation:

Market Breakup: By Product Type

Standalone Workstations

Integrated Workstations

Market Breakup: By Modality

Magnetic Resonance Imaging (MRI)

Computed Tomography (CT)

Mammography

Positron Emission Tomography (PET)

Single-Photon Emission Computed Tomography (SPECT)

Market Breakup: By End-User

Hospitals

Diagnostic Imaging Centers

Research Institutes

Market Breakup: By Application

Cardiology

Oncology

Neurology

Orthopedics

Dental

Others

Click Here : https://organicmarketresearch.com/imaging-workstationsmarket

Regional Analysis

The size and scope of the global Imaging Workstations market vary by region and are important and expanding. Below is a quick summary of the industry’s regional analysis:

North America: The North American market is the largest market for imaging workstations and is driven by the presence of advanced healthcare infrastructure, high healthcare expenditure, and the adoption of new technologies. The United States is the major contributor to the market in this region.

Europe: The European market for imaging workstations is driven by the increasing prevalence of chronic diseases, the growing demand for early diagnosis, and the development of advanced imaging technologies. The major markets in this region include Germany, France, and the UK.

Asia-Pacific: The Asia-Pacific region is the fastest-growing market for imaging workstations, driven by the increasing healthcare expenditure, growing awareness about early diagnosis and treatment, and the presence of a large patient population. The major markets in this region include China, Japan, India, and South Korea.

South America: The South American market for imaging workstations is driven by the improving healthcare infrastructure and the growing demand for advanced medical technologies. Brazil is the major contributor to the market in this region.

Middle East & Africa: The Middle East & Africa market for imaging workstations is driven by the increasing healthcare expenditure, growing demand for advanced medical technologies, and the presence of a large patient population. The major markets in this region include Saudi Arabia, the UAE, and South Africa.

Overall, the imaging workstations market is growing in all regions due to the increasing prevalence of chronic diseases, the growing demand for advanced medical technologies, and the increasing healthcare expenditure. However, the rate of growth and market size vary across different regions.

Market Breakup By Region

North America

Europe

Asia Pacific

Latin America

Middle East and Africa

Competitive Landscape

The Imaging Workstations Industry competitive landscape provides details by competitor. Details included are company outline, company financials, revenue generated, market potential, investment in research and development, new market initiatives, worldwide occurrence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The overhead data points providing are only related to the businesses’ focus related to Imaging Workstations marketplace.

Major players operating in the Global Imaging Workstations Industry are:

General Electric Company

Siemens Healthineers AG

Koninklijke Philips N.V.

Canon Medical Systems Corporation

Fujifilm Holdings Corporation

Hologic, Inc.

Carestream Health, Inc.

Agfa-Gevaert N.V.

Accuray Incorporated

Capsa Healthcare

NDS Surgical Imaging LLC

Carl Zeiss Meditec AG

Esaote SpA

Pie Medical Imaging

Ziehm Imaging GmbH

Trending Reports:

https://organicmarketresearch.com/imaging-workstationsmarkethttps://organicmarketresearch.com/diy-pc-gaming-chassis-market

[mrfr-blogs]

Evaluating Market Size and Growth Potential in Diagnostic Imaging Market

Market Overview –

The diagnostic imaging market is anticipated to reach USD 49.66 billion by 2032, growing at a CAGR of 4.7% over the forecast period 2023-2032.

The Diagnostic Imaging Market encompasses a wide range of medical imaging technologies used to visualize internal body structures and diagnose various medical conditions. These imaging modalities include X-ray, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, and nuclear medicine techniques such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT).

The diagnostic imaging market is thriving, propelled by advancements in medical imaging technologies. Medical imaging plays a crucial role in disease detection, diagnosis, and treatment planning. With continuous innovation, such as AI integration and portable imaging devices, the market is witnessing sustained growth, meeting the increasing demand for accurate and efficient diagnostic solutions.

In recent years, the diagnostic imaging market has experienced significant growth globally due to several factors. Firstly, there has been increasing demand for diagnostic imaging procedures driven by factors such as aging populations, rising prevalence of chronic diseases, and advancements in imaging technology. Key players in this market include medical device manufacturers, imaging equipment suppliers, healthcare providers, and research institutions, collaborating to develop and commercialize innovative imaging solutions.

Moreover, advancements in imaging technology have led to the development of new imaging modalities with improved resolution, speed, and diagnostic accuracy. These advancements enable earlier detection of diseases, more precise treatment planning, and better monitoring of treatment response, ultimately leading to improved patient outcomes.

Additionally, there is growing interest in personalized imaging approaches tailored to individual patient characteristics, such as genetic profiles, disease stage, and treatment history. Personalized imaging techniques enable healthcare providers to optimize imaging protocols and treatment strategies based on each patient's unique needs, enhancing the efficacy and safety of medical imaging procedures.

Overall, the diagnostic imaging market presents opportunities for growth and innovation as it continues to evolve with advancements in technology and increasing demand for diagnostic imaging services worldwide. Efforts to develop new imaging modalities, improve imaging quality, and expand access to imaging services are essential for advancing healthcare practices and improving patient care.

Market Segmentation –

The global diagnostic imaging market has been segmented on the basis of product, source, and application.

Based on  product type, the market has been divided into x-ray equipment, ultrasound imaging systems, nuclear imaging systems, magnetic resonance imaging (MRI), computed tomography (CT) scanners, and other products

The market, by application, has been segmented into gynecology, oncology, orthopedics, cardiology, gastroenterology, neurology, and other applications

The end-user segment has been further divided into hospitals and clinics, diagnostic centers, research institutes, and others.

Regional Analysis –

Regional analysis of the diagnostic imaging market is essential for understanding the adoption, trends, and dynamics of imaging modalities across different geographic regions. Diagnostic imaging plays a crucial role in healthcare by enabling the visualization of internal body structures for diagnosis, monitoring, and treatment planning. Factors such as healthcare infrastructure, reimbursement policies, and prevalence of diseases influence the demand for various imaging technologies in each region.

Developed regions like North America and Europe often lead in the adoption of advanced imaging modalities such as MRI, CT scans, and PET scans due to well-established healthcare systems, high healthcare spending, and early adoption of innovative medical technologies. In contrast, emerging economies in Asia-Pacific and Latin America are witnessing increasing demand for diagnostic imaging, driven by factors such as rising healthcare expenditure, improving access to healthcare services, and growing prevalence of chronic diseases. Additionally, variations in regulatory frameworks and cultural attitudes towards healthcare impact market dynamics and adoption rates across regions.

Conducting a comprehensive regional analysis enables stakeholders to identify market opportunities, tailor their marketing strategies, and address region-specific challenges such as regulatory compliance and market access. By understanding regional nuances, companies can optimize their market penetration efforts and better serve the diagnostic imaging needs of healthcare providers and patients worldwide.

Key Players –

The Diagnostic imaging company profiles include Koninklijke Philips N.V., CANON MEDICAL SYSTEMS CORPORATION, Carestream Health, Esoate SpA, GE Healthcare, Toshiba Medical Systems Corporation, FUJIFILM Holdings Corporation, Siemens Healthcare Private Limited, Hitachi Medical Systems, Hologic Inc., and Shimadzu Corporation.

Related Reports –

Macrolide Antibiotics

Spinal Traction

Performance Enhancing Drugs

Vasectomy

For more information visit at MarketResearchFuture

[researchinsighthub]

Nuclear Imaging Equipment Market Size, Share, CAGR, Worth, Key Players, Analysis & Forecast 2032

Emergen Research's latest market research report, titled Global Nuclear Imaging Equipment Market, provides estimated market size and shares, latest industry trends, global market growth rates, key drivers and opportunities, constraints, product segmentation, and major market players. Cost structure, market size, competitive landscape, product portfolio and specifications, and company profiles.

This report is a fair prototype of the Nuclear Imaging Equipment-industry containing an in-depth study of the global Nuclear Imaging Equipment market. This report serves as a valuable source of data and information related to this industry. It covers various industry aspects with a particular focus on market scope and application areas. The report identifies the fundamental business strategies adopted by industry experts and offers an insightful study on the value chains and distribution channels of the global market. The report authors have also analyzed current industry trends, growth potential, current overview, and market limitations.

The global nuclear imaging equipment market size was USD 2.97 Billion in 2022 and is expected to register a steady revenue CAGR of 4.9% during the forecast period, according to latest analysis by Emergen Research. The Nuclear Imaging Equipment market has experienced substantial growth in recent years, driven by advancements in technology, increasing prevalence of chronic diseases, and the growing demand for accurate diagnostic imaging. Nuclear imaging involves the use of radioactive substances to create images of the body's organs and tissues, allowing healthcare professionals to diagnose and monitor various medical conditions. It is widely used in cardiology, oncology, neurology, and other medical specialties.

A report by the International Atomic Energy Agency (IAEA) stated that the number of PET-CT and SPECT-CT units worldwide has been steadily increasing over the years, indicating the growing adoption of nuclear imaging technologies. Furthermore, the Centers for Medicare and Medicaid Services (CMS) reported that the reimbursement rates for nuclear imaging procedures have remained stable, demonstrating the importance of these imaging modalities in clinical practice.

One of the key drivers of the Nuclear Imaging Equipment market is the continuous technological advancements in imaging systems. Manufacturers are constantly developing innovative technologies that enhance image quality, reduce radiation exposure, and improve the overall efficiency of nuclear imaging procedures. For example, the introduction of hybrid imaging systems such as positron emission tomography-computed tomography (PET-CT) and single-photon emission computed tomography-computed tomography (SPECT-CT) has revolutionized diagnostic imaging by combining anatomical and functional information in a single scan. These advancements have led to more accurate diagnoses, improved patient outcomes, and increased adoption of nuclear imaging equipment.

The increasing prevalence of chronic diseases, such as cancer and cardiovascular diseases, is another major driver of the Nuclear Imaging Equipment market. Nuclear imaging techniques play a crucial role in the early detection, staging, and monitoring of these diseases. For instance, PET-CT scans are widely used in oncology to identify tumor location, assess treatment response, and monitor disease progression. As the global burden of chronic diseases continues to rise, there is a growing demand for advanced diagnostic tools like nuclear imaging equipment to aid in disease management and improve patient care.

However, there are also certain restraints and challenges that the Nuclear Imaging Equipment market faces. One of the primary restraints is the high cost associated with these imaging systems. Nuclear imaging equipment is complex and requires specialized infrastructure, radioactive materials, and trained personnel, making it expensive to procure and operate. The cost factor can limit the adoption of nuclear imaging equipment, particularly in resource-constrained healthcare settings. Additionally, the strict regulatory requirements and safety considerations associated with the use of radioactive materials pose challenges for market growth.

Additionally, researchers have closely examined the significant changes in the market following the coronavirus outbreak. This is the latest report examining the economic situation of the Nuclear Imaging Equipment industry after the current pandemic. The COVID-19 pandemic has significantly changed various aspects of the global Nuclear Imaging Equipment market scenario. The latest report provides a comprehensive COVID-19 impact analysis of the market, helping readers to know about the significant impact of the outbreak on the current and future scenarios of this business.

Get Free Sample Report, visit @https://www.emergenresearch.com/request-sample/1939

Key market aspects studied in the report:

Market Scope: The report explains the scope of various commercial possibilities in the global Nuclear Imaging Equipment market over the upcoming years. The estimated revenue build-up over the forecast years has been included in the report. The report analyzes the key market segments and sub-segments and provides deep insights into the market to assist readers with the formulation of lucrative strategies for business expansion.

Competitive Outlook: The leading companies operating in the Nuclear Imaging Equipment market have been enumerated in this report. This section of the report lays emphasis on the geographical reach and production facilities of these companies. To get ahead of their rivals, the leading players are focusing more on offering products at competitive prices, according to our analysts.

Report Objective: The primary objective of this report is to provide the manufacturers, distributors, suppliers, and buyers engaged in this sector with access to a deeper and improved understanding of the global Nuclear Imaging Equipment market.

To seek a discount on this report, click on the link: @https://www.emergenresearch.com/request-discount/1939

Competitive Terrain:

The global Nuclear Imaging Equipment industry is highly consolidated owing to the presence of renowned companies operating across several international and local segments of the market. These players dominate the industry in terms of their strong geographical reach and a large number of production facilities. The companies are intensely competitive against one another and excel in their individual technological capabilities, as well as product development, innovation, and product pricing strategies.

Leading Market Players Profiled in the Report:

Siemens Healthcare GmbH, Koninklijke Philips N.V., DIGIRAD HEALTH, INC., GE HealthCare., SurgicEye GmbH, Rigaku Corporation, Neusoft Corporation., Segami, FUJIFILM Holdings Corporation, and Mirion Technologies, Inc

Regional Outlook:

North America (the U.S., Canada, Mexico)

Europe (the U.K., Germany, France, Italy)

Asia Pacific (India, China, Japan, Korea)

Latin America (Brazil, Argentina, Ecuador, Chile)

Middle East & Africa (Egypt, Turkey, Saudi Arabia, Iran)

Key reasons to buy the Global Nuclear Imaging Equipment Market report:

The latest report comprehensively studies the global Nuclear Imaging Equipment market size and provides useful inference on numerous aspects of the market, such as the current business trends, market share, product offerings, and product share.

The report offers an insightful analysis of the regional outlook of the market.

It offers a detailed account of the end-use applications of the products & services offered by this industry.

The report holistically covers the latest developments taking place in this industry. Therefore, it lists the most effective business strategies implemented by the market rivals for ideal business expansion.

Request customization of the report @https://www.emergenresearch.com/request-for-customization/1939

Related Reports:

water treatment biocides market https://www.emergenresearch.com/industry-report/water-treatment-biocides-market

ai in banking market https://www.emergenresearch.com/industry-report/ai-in-banking-market

computer aided diagnostics market https://www.emergenresearch.com/industry-report/computer-aided-diagnostics-market

robotics surgical simulation systems market https://www.emergenresearch.com/industry-report/robotics-surgical-simulation-systems-market

powered agriculture equipment market https://www.emergenresearch.com/industry-report/powered-agriculture-equipment-market

Thank you for reading our report. For further details or to inquire about customization, please let us know and we will offer you the report as per your needs.

About Emergen Research Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy

Contact Us: Eric Lee Corporate Sales Specialist Emergen Research | Web: https://www.emergenresearch.com/  Direct Line: +1 (604) 757-9756  E-mail: sales@emergenresearch.com  Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights 

[vanshika393]

Medical Imaging Equipment Market Size Expected To Acquire USD 48,786.03 million By 2030 At CAGR of 5.60%

The latest market report published by Credence Research, Inc. “Global Medical Imaging Equipment Market: Growth, Future Prospects, and Competitive Analysis, 2016 – 2030. The market for medical imaging equipment has been expanding steadily in recent years, and between 2023 and 2030, it is anticipated to rise at a CAGR of 5.60%. The market was estimated to be worth USD 31,548.9 million in 2022, and it is anticipated to be worth USD 48,786.03 million in 2030.

Medical Imaging Equipment Market Overview:

The Medical Imaging Equipment Market refers to the global industry that produces and sells various devices used to create visual representations of the interior of a body for clinical analysis and medical intervention. These devices play a crucial role in diagnosing, monitoring, and treating various medical conditions by providing valuable insights into the structure and functioning of internal organs and tissues. The market includes a wide range of imaging modalities, each with its own technology and applications.

Types of Medical Imaging Equipment:

Computed Tomography (CT) Scanners: CT scanners use a series of X-ray images taken from different angles to create detailed cross-sectional images of the body. They are especially useful for visualizing internal structures in 3D.

Magnetic Resonance Imaging (MRI) Systems: MRI uses strong magnetic fields and radio waves to generate detailed images of soft tissues, organs, and the nervous system. It's particularly valuable for diagnosing neurological and musculoskeletal conditions.

Ultrasound Machines: Ultrasound imaging uses high-frequency sound waves to create images of internal structures. It's commonly used for monitoring pregnancies, examining organs, and guiding procedures.

Nuclear Medicine Equipment: This category includes equipment like Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) scanners. These technologies use radioactive tracers to visualize organ function and metabolism.

Partnerships and Collaborations:

Siemens Healthineers and Novartis: Siemens Healthineers entered into a partnership with Novartis to develop and commercialize assays measuring blood levels of certain therapeutic drugs using Siemens' Atellica Solution immunoassay analyzer. This collaboration aimed to enhance personalized treatment and monitoring of patients.

Philips and B. Braun Melsungen: Philips and B. Braun Melsungen collaborated in 2020 to provide an integrated regional solution for continuous ultrasound-guided regional anesthesia. The collaboration aimed to improve patient care during surgery by combining B. Braun's regional anesthesia expertise with Philips' ultrasound technology.

GE Healthcare and Roche: GE Healthcare and Roche collaborated in 2020 to develop and market digital diagnostics solutions, combining Roche's expertise in in-vitro diagnostics with GE Healthcare's expertise in medical imaging and monitoring.

Acquisitions:

Philips Acquires BioTelemetry: Philips acquired BioTelemetry, a company specializing in remote cardiac diagnostics and monitoring. This acquisition aimed to expand Philips' remote patient monitoring offerings and enhance its digital healthcare solutions.

Siemens Healthineers Acquires Varian Medical Systems: Siemens Healthineers completed the acquisition of Varian Medical Systems, a company known for its advanced radiation therapy solutions for cancer treatment. This acquisition aimed to strengthen Siemens Healthineers' oncology portfolio.

Canon Medical Systems Acquires Delft Imaging Systems: Canon Medical Systems acquired Delft Imaging Systems, a company focused on providing medical imaging solutions for low-resource settings. This acquisition aimed to enhance Canon's efforts to provide healthcare solutions to underserved regions.

Browse 240 pages report By End-User (Hospitals, Diagnostic Imaging Centers, Specialty Clinics, Ambulatory Care Centers) By Technology (Digital Imaging, Analog Imaging, 3D and 4D Imaging, Portable and Point-of-Care Imaging) By Specialty and Advanced Features Contrast-Enhanced Imaging, Functional Imaging, Interventional Imaging, Molecular Imaging) Growth, Future Prospects & Competitive Analysis, 2016 – 2030 -  https://www.credenceresearch.com/report/medical-imaging-equipment-market

Here are some of the significant growth factors:

Technological Advancements: Continuous advancements in medical imaging technology, such as MRI, CT scans, ultrasound, and X-ray systems, have played a pivotal role in market growth. Improved imaging quality, faster scans, and reduced radiation exposure have expanded the applications and adoption of these technologies.

Aging Population: The global population is aging, leading to an increased demand for medical imaging services. As people age, they are more likely to require medical imaging for diagnostic purposes and disease management.

Rising Chronic Diseases: The prevalence of chronic diseases such as cancer, cardiovascular diseases, and orthopedic conditions is on the rise. These conditions often require diagnostic imaging for accurate diagnosis and treatment planning.

Emerging Markets: Developing countries are expanding their healthcare infrastructure, increasing access to medical imaging services. This has led to a significant market growth in regions like Asia-Pacific, Latin America, and the Middle East.

Why to Buy This Report-

The report provides a qualitative as well as quantitative analysis of the global Medical Imaging Equipment Market by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics with the historical period from 2016-2020, the base year- 2021, and the projection period 2022-2028.

The report includes information on the competitive landscape, such as how the market's top competitors operate at the global, regional, and country levels.

Major nations in each region with their import/export statistics

The global Medical Imaging Equipment Market report also includes the analysis of the market at a global, regional, and country-level along with key market trends, major players analysis, market growth strategies, and key application areas.

Browse Full Report: https://www.credenceresearch.com/report/medical-imaging-equipment-market

Visit: https://www.credenceresearch.com/

Related Report: https://www.credenceresearch.com/report/ambulatory-surgery-centers-market

https://www.credenceresearch.com/report/veterinary-surgical-sutures-market

Browse Our Blog: https://www.linkedin.com/pulse/medical-imaging-equipment-market-grow-steadily-over-cagr-shukla

About Us -

Credence Research is a viable intelligence and market research platform that provides quantitative B2B research to more than 10,000 clients worldwide and is built on the Give principle. The company is a market research and consulting firm serving governments, non-legislative associations, non-profit organizations, and various organizations worldwide. We help our clients improve their execution in a lasting way and understand their most imperative objectives. For nearly a century, we’ve built a company well-prepared for this task.

Contact Us:

Office No 3 Second Floor, Abhilasha Bhawan, Pinto Park, Gwalior [M.P] 474005 India

[priyanshisingh]

Radiopharmaceutical Theranostics Market Size, Industry Share, Growth Demand, Supply Chain, Trends Future Outlook, Forecast 2030

The latest market report published by Credence Research, Inc. “Global Radiopharmaceutical Theranostics Market: Growth, Future Prospects, and Competitive Analysis, 2016 – 2028. Steady growth in recent years is expected to grow at a CAGR of 11.90% between 2022 and 2030. The market was valued at USD 1.6 billion in 2022 and is expected to reach USD 3.52 billion in 2030.

Radiopharmaceutical theranostics market dynamics play a crucial role in the advancement of personalized medicine and targeted therapy. The term "theranostics" combines diagnostics and therapy, highlighting the dual functionality of radiopharmaceuticals in both identifying disease biomarkers and delivering therapeutic interventions. This rapidly evolving field is driven by several key factors that shape its dynamic landscape. Technological advancements in imaging techniques, such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT), have significantly improved diagnostic accuracy and aided treatment decision-making processes. Additionally, the increasing prevalence of chronic diseases, including cancer and cardiovascular disorders, has surged the demand for precise molecular imaging tools capable of guiding effective treatment strategies.

Global Disease Burden Amplifying Market Growth

The mounting global burden of chronic diseases, particularly cancer and neurodegenerative disorders, plays a pivotal role in propelling the radiopharmaceutical theranostics market. Advances in theranostics have shown significant promise in addressing these health challenges, making them a focal point in the healthcare sector's battle against chronic diseases.

Technological Innovations as Market Catalysts

Innovation is at the heart of the radiopharmaceutical theranostics market's surge. Groundbreaking developments in medical imaging technologies, such as PET and SPECT, and novel radioisotope therapies are stimulating market growth. The fusion of these technologies has birthed an era of targeted, efficient, and minimally invasive treatment options.

Market Segmentation:

By Application: Cancer Remains the Leading Segment

Cancer theranostics remains the predominant market segment, driven by the ever-increasing global cancer incidence. The advent of radiopharmaceuticals like Lutathera and Azedra has transformed the oncology landscape, offering groundbreaking solutions for neuroendocrine tumors and pheochromocytoma.

By End-user: Hospitals and Diagnostic Centers Lead the Way

Hospitals and diagnostic centers represent the leading end-user segment. These institutions are at the forefront of adopting radiopharmaceutical theranostics due to their comprehensive treatment capabilities and access to advanced medical imaging modalities.

Browse 210 pages report Radiopharmaceutical Theranostics Market By Radioisotope (Technetium-99, Gallium-68, Iodine-131, Radium-223, Fluorine-18) By Application (Oncology, Cardiology, Others) - Growth, Future Prospects & Competitive Analysis, 2016 – 2030)- https://www.credenceresearch.com/report/radiopharmaceutical-theranostics-market

Regional Market Dynamics:

North America: The Dominant Player

North America retains its stronghold on the radiopharmaceutical theranostics market. This is attributable to the region's robust healthcare infrastructure, advanced research facilities, and high adoption rate of innovative medical technologies.

Europe and Asia-Pacific: Regions on the Rise

Europe and Asia-Pacific regions are also notable market players. Europe's progress is driven by its sophisticated healthcare systems and a strong focus on research and development. Asia-Pacific, meanwhile, benefits from a booming healthcare sector and an increasing prevalence of chronic diseases.

Key Market Players:

Dominant players in the global radiopharmaceutical theranostics market include Novartis AG, Advanced Accelerator Applications, and Progenics Pharmaceuticals. Their innovative strides in radioisotope production, medical imaging, and theranostic applications shape the industry's landscape and future trajectory.

The Road Ahead: Future Perspectives in Radiopharmaceutical Theranostics

As we look to the future, the radiopharmaceutical theranostics market is set to witness continued growth. Aided by technological advancements, increased healthcare spending, and an unyielding commitment to improving patient outcomes, the theranostic revolution will continue to flourish, transforming the way we diagnose and treat diseases.

Why to Buy This Report-

The report provides a qualitative as well as quantitative analysis of the global Radiopharmaceutical Theranostics Market by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics with the historical period from 2016-2020, the base year- 2021, and the projection period 2022-2028.

The report includes information on the competitive landscape, such as how the market's top competitors operate at the global, regional, and country levels.

Major nations in each region with their import/export statistics

The global Radiopharmaceutical Theranostics Market report also includes the analysis of the market at a global, regional, and country-level along with key market trends, major players analysis, market growth strategies, and key application areas.

Browse Full Report: https://www.credenceresearch.com/report/radiopharmaceutical-theranostics-market

Visit: https://www.credenceresearch.com/

Related Report: https://www.credenceresearch.com/report/big-data-spending-in-healthcare-market

Related Report: https://www.credenceresearch.com/report/microbiological-safety-cabinets-market

Browse Our Blog: https://www.linkedin.com/pulse/radiopharmaceutical-theranostics-market-grow-steadily-priyanshi-singh

Browse Our Blog: https://tealfeed.com/radiopharmaceutical-theranostics-market-size-worth-usd-lk484

About Us -

Credence Research is a viable intelligence and market research platform that provides quantitative B2B research to more than 10,000 clients worldwide and is built on the Give principle. The company is a market research and consulting firm serving governments, non-legislative associations, non-profit organizations, and various organizations worldwide. We help our clients improve their execution in a lasting way and understand their most imperative objectives. For nearly a century, we’ve built a company well-prepared for this task.

Contact Us:

Office No 3 Second Floor, Abhilasha Bhawan, Pinto Park, Gwalior [M.P] 474005 India

[market-insider]

Preclinical Imaging Market Report | Multimodal Imaging Segment Expected To Witness Significant Growth

The global preclinical imaging market size is expected to reach USD 5.4 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 3.8% from 2022 to 2030. Heavy investments in research and development are encouraging research projects worldwide. As a result, the demand for preclinical imaging is steadily increasing. Pharmaceuticals, biotechnology, life sciences, medical devices, and cosmetics are wide application areas, where imaging modalities are widely used in research and development. Furthermore, veterinary hospitals and educational institutions also create additional demand for this market.

Gain deeper insights on the market and receive your free copy with TOC now @: Preclinical Imaging Market Report

Nuclear medicine techniques (primarily, positron emission tomography [PET] and single-photon emission computed tomography [SPECT]), optical imaging, micro computed tomography (CT), micro magnetic resonance imaging (MRI), Photoacoustic tomography (PAT) and ultrasound are the most suitable modalities for small-animal in vivo imaging applications. Each modality has its own set of benefits and drawbacks. The multimodality devices designed to give complementary information on the pathophysiological process under research have rapidly gained popularity, seeking to overcome the inherent limits of each imaging modality.

The combination of high-resolution modalities such as micro-CT and micro-MRI with highly sensitive techniques that provide functional information like micro-PET or micro-SPECT is expected to broaden the horizons of research in key areas like infection, oncology, cardiology, and neurology, contributing not only to the understanding of disease underlying mechanisms but also providing efficient and unique tools for evaluating new chemical entities and candidate drugs, thus boosting the market growth.

The market's prominent competitors are taking different initiatives such as funding’s and acquisitions of medium and small-sized businesses in order to expand their product portfolio and enhance their manufacturing capacity. For instance, In November 2021, Bruker Corporation acquired MOLECUBES NV, a dynamic innovator in benchtop preclinical nuclear molecular imaging systems. This acquisition is expected to strengthen Bruker's position as a leading supplier in preclinical and translational imaging research.

[megharesearch]

The Single-photon Emission Computed Tomography (SPECT) Systems market research report discusses the importance of the segments as well as the regional markets. An accurate overview of different segments and regions has been prepared on the basis of the market size as well as the growth rate (CAGR). Different industry professionals and research analysts in various regions have examined and validated the data presented in this research report.

[vynzresearchindia]

Global Image Guided Surgery Devices Market Size, Share and Demand Forecast to 2027 | VynZ Research

The Global Image Guided Surgery Devices Market size will reach USD 9.3 billion by 2027 and is expected to develop at a CAGR of 7.3% during the forecast period (2021-2027), according to VynZ Research. For the forecast year 2021-2027, as well as the historical period 2015-2020, the Global Image-Guided Surgery Devices Market has been studied.

The research report provides a comprehensive and insightful examination of the Global Image-Guided Surgery Devices Market and includes market analysis on segmentation, dynamics, competition, and regional development. It considers the Global Image-Guided Surgery Devices Market's CAGR, value, volume, revenue, production, consumption, sales, manufacturing cost, pricing, and other significant parameters. The forecasts in the report are based on well-established research methodology and assumptions.

Get the sample copy of the Market Research @ https://www.vynzresearch.com/healthcare/image-guided-surgery-devices-market/request-sample

Individual strategies were examined in the Global Image-Guided Surgery Devices Market study, followed by business profiles of Global Image-Guided Surgery Devices Market providers. The study includes an 'Industry Landscape' section that provides readers with a comprehensive view and firms’ market share analysis of major industry players in the Global Image-Guided Surgery Devices Market.

Most of the major players in the Global Image Guided Surgery Devices Market are profiled in the report. The strengths and weaknesses, business developments, recent innovations, mergers and acquisitions, expansion plans, global footprint, market presence, and product portfolios of key market competitors are all covered in the company profiling section.

The following are some of the major and developing players in the Global Image-Guided Surgery Devices Market:

Siemens AG

Koninklijke Philips N.V

Medtronic Plc

Stryker Corporation

Hitachi Ltd.

Varian Medical Systems Inc.

Smith & Nephew Plc

KARL STORZ GmbH & Co. KG.

General Electric Company

Zimmer Holdings Inc.

Breakdown of The Segments:

The Global Image-Guided Surgery Devices Market is segmented by Source, Service Type, Application, and Geography in this study. This segmentation aids executives in planning their products and budgets depending on each segment's expected growth rates.

By Product

X-Ray Fluoroscopy

Computed Tomography (CT)

Magnetic Resonance Imaging (MRI)

Ultrasound

Endoscopes

Single-Photon Emission Computed Tomography (SPECT)

Positron Emission Tomography (PET)

By Application

Cardiac Surgery

Neurosurgery

Orthopedic Surgery

Urology

Gastroenterology

Oncology Surgery

Others

By End User

Hospitals

Ambulatory Surgical Centers (ASCs)

Others

Geographical Viewpoint:

The research overview provides the major industry trend and the global market's predicted volume based on the regional analysis. The elements that have driven and hampered the market's expansion are also mentioned in this market research analysis. The study is also equipped with the most advanced and effective techniques for gathering, recording, estimating, and evaluating market data.

FAQ

Who are the most dominant players in the global market, and what elements are assisting them in gaining a competitive advantage?

What are the strategies adopted by the key industry players to gain traction in the industry?

By the end of the forecast period, what will the market size and growth rate?

What are the biggest Global Image-Guided Surgery Devices Market trends that are influencing market growth?

In the global market, which segment had the biggest revenue share?

Explore More Reports by VynZ Research:

Global Beauty Devices Market – Analysis and Forecast (2022-2030)

Global Immunoassay Market – Analysis and Forecast (2022–2030)

Global Diagnostic Imaging Market – Analysis and Forecast (2022-2030)

Global Skincare Devices Market – Analysis and Forecast (2022-2030)

About VynZ Research

VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. VynZ have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies.

[healthcare-market]

Cardiopulmonary Stress Testing Systems Market Growth Trends, Current Demand, and Development Report

Transparency Market Research (TMR) has published a new report titled, ‘Cardiopulmonary Stress Testing Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global Cardiopulmonary Stress Testing Systems market was valued at US$ 4.5 Bn in 2018 and is projected to expand at a CAGR of 5.9 % from 2019 to 2027.

Overview

Cardiopulmonary stress testing is performed to evaluate exercise capacity and predict outcome in patients diagnosed with heart failure. It is a non-invasive and highly sensitive stress test that evaluates the response of cardiovascular, pulmonary, neurophysiological, hematopoietic, and skeletal muscle systems to exercise. CPST plays an important role in the detection of ischemic heart disease, heart failure, shortness of breath, asthma, and other pulmonary disorders.

The primary goal of cardiac stress testing is to identify the risk stratification of coronary artery disease (CAD), which is one of the most common causes of deaths globally. It is a progressive condition that leads to the obstruction of blood vessels in the arteries providing blood to the heart muscles.

North America dominated the global cardiopulmonary stress testing systems market in 2018 and the trend is anticipated to continue during the forecast period. Continued adoption of cardiac monitoring equipment, presence of leading manufacturers of cardiac systems and rising prevalence of coronary artery diseases are expected to drive the market in North America.

Asia Pacific is likely to be a highly lucrative market for cardiopulmonary stress testing systems and it is expected to expand at a high CAGR during the forecast period owing to increasing disposable income, rise in geriatric population, and rising number of patients diagnosed with cardiovascular diseases and increase in adoption of advanced diagnosis & monitoring devices.

Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1530

Rise in Geriatric Population to Drive Market

There has been an unprecedented growth in the global geriatric population. According to the World Health Organization (WHO), people above the age of 65 years form the fastest growing population segment globally. The percentage of the population above 60 years of age across the globe is projected to double from 11% to 22% between 2000 and 2050. It also stated that 80% of older people will be living in low- and middle-income countries in 2050.

Moreover, the global geriatric population would grow at the fastest rate in developed countries such as the U.S., the U.K., and Japan. Brazil, China, Thailand, and South Korea are expected to have a large geriatric population in a short span of time in the near future.

Therefore, increase in geriatric population thereby increases the risk of coronary artery disease as this group of individuals are prone to cardiac disorders due to high total serum cholesterol levels.

According to the article published by the National Center for Biotechnology Information) NCBI, Coronary artery disease accounts for 82% deaths in people aged 65 years and above. The prevalence rate of coronary heart disease in the U.S. is likely to increase by 26% between 2010 and 2040.

Request for Analysis of COVID19 Impact on Cardiopulmonary Stress Testing Systems Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1530

CPET Systems Segment to Dominate Market

Based on type, the global cardiopulmonary stress testing systems market has been divided into CPET systems, stress ECG, pulse oximeters, stress BP monitors and single-photon emission computed tomography (SPECT). The CEPT system segment has been bifurcated into stationary and portable. The CPET systems segment dominated the global cardiopulmonary stress testing systems market in 2018 and the trend is projected to continue during the forecast period. Rapid adoption of CPET among professional athletes and technological enhancement in testing equipment to accelerate the growth of the segment.

Request a Sample of Cardiopulmonary Stress Testing Systems Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1530

North America to Dominate Global Market

In terms of region, the global cardiopulmonary stress testing systems market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global cardiopulmonary stress testing systems market in 2018, followed by Europe.

North America accounted for major share of the global Cardiopulmonary Stress Testing Systems market in 2018. Availability of cardiac care facilities, increase in investment supporting medical treatment, and rising prevalence of cardiovascular diseases are expected to drive the growth of the market in the region. According to the Centers for Disease Control and Prevention (CDC), one in every four deaths in U.S. is due to heart disease. Coronary heart disease is the most common type of heart disease that accounts for nearly 370,000 deaths in the U.S. each year

Enquiry before Buying Cardiopulmonary Stress Testing Systems Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=1530

Competitive Landscape

The global cardiopulmonary stress testing systems market is fragmented in terms of number of players. Key players in the global market include General Electric Company, Koninklijke Philips N.V., CareFusion Corporation (BD), Spacelabs Healthcare (OSI Systems, Inc.), COSMED srl, MGC Diagnostic Corporation, Nihon Kohden Corporation, Schiller AG, SunTech Medical, Inc. and Welch Allyn among others

More Trending Reports by Transparency Market Research:

Drug Discovery Outsourcing Market The competitions to develop and market new drugs at slim profit margins have caught on momentum worldwide. In the backdrop of these factors, new operational models have stridently helped client companies not only invigorate their drug pipeline but stop a receding bottom-line. New possibilities will veritably emerge anchored on which biotech companies will engage with CROs.

Respiratory Virus Vaccines Market  The category of inactivated/killed vaccines is estimated to account for a significant part of the global market. The development of novel vaccinations and extensive research programmes for the inactivated/killed vaccines are expected to drive the industry over the forecast timeline, from 2020 to 2030.

Surgical Microscopes Market  Rise in number of tumor surgeries in hospitals, ambulatory surgical centers (ASCs), coupled with attractive reimbursement frameworks in some regions, is a major trend for the surgical microscopes market evolution. Another prominent push for demand has come from rapidly rising geriatric population.

About Us Section:

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

Contact Us

Rohit Bhisey Transparency Market Research, 90 State Street, Suite 700, Albany, NY 12207 Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com

[marketresearch-articles]

Nuclear Medicine Equipment Market trends and outlook 2021-28

Nuclear medicine equipment market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 6.7% in the above mentioned forecast period.

The introduction of advanced nuclear medicine equipment has been increasing on a significant pace, thereby motivating as well as lifting the growth of the nuclear medicine equipment market. In addition, the growing awareness regarding the importance of early diagnosis of diseases as well as the high adoption of nuclear medicine equipment by end users further propels the high adoption rate offered in the market for nuclear medicine equipment. Also the high investment in renovations of diagnostic imaging centers, development of new radiotracers is also fueling the demand of the nuclear medicine equipment market over the forecast period of 2021 to 2028. 

.

 This nuclear medicine equipment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on nuclear medicine equipment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

 Download Sample report @ https://www.databridgemarketresearch.com/request-a-sample?dbmr=global-nuclear-medicine-equipment-market

 The major players covered in the nuclear medicine equipment market report are CMR Naviscan, SurgicEye GmbH, Mallinckrodt, Neusoft Corporation, DDD-Diagnostic A/S, CANON MEDICAL SYSTEMS CORPORATION, Mediso Ltd, DIGIRAD CORPORATION, Siemens, Cardinal Health, GENERAL ELECTRIC, Koninklijke Philips N.V., FUJIFILM Holdings Corporation, Bozlu Holding, Compañía Mexicana de Radiología CRG, SA de CV, TOSHIBA CORPORATION, Bartec Technologies Ltd., Biodex, Cyclopharm and Standard Imaging Inc., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

 Get Details TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-nuclear-medicine-equipment-market

  Global Nuclear Medicine Equipment Market Scope and Market Size

Nuclear medicine equipment market is segmented on the basis of product type, application and end user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

Based on product type, the nuclear medicine equipment market is segmented into single photon-emission computed tomography (SPECT), hybrid pet and planar scintigraphy. Single photon-emission computed tomography (SPECT) is further segmented into standalone SPECT systems and hybrid SPECT systems.

The application segment of the nuclear medicine equipment market is segmented into cardiology, oncology, neurology, general imaging, and other applications.

On the basis of end user, the nuclear medicine equipment market is segmented into hospitals, imaging centers, academic and research centers and other end users.

View complete report @ 

https://www.databridgemarketresearch.com/reports/global-nuclear-medicine-equipment-market

 Customization Available : Global Nuclear Medicine Equipment Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.

  Browse related report @ Breast Pumps Market 

                                        C-Arms Market

                                        CADASIL treatment market

                                         Candidiasis Therapeutics Market

                                         Cardiac Rehabilitation Market

[reportsjournal]

Nuclear Imaging Equipment Market Analysis, Size, Share, Growth Trends and Forecasts 2021 - 2028

The global nuclear imaging equipment market size is expected to reach USD 3.5 billion by 2028, registering a CAGR of 4.6% over the forecast period, according to the latest report by Reports and Data. Major factors driving market revenue growth are increasing focus on personalized medicines and technological advancements in radiotracers. Furthermore, demand growth is expected to enhance by expansion of pharmaceutical industries and rising prevalence of chronic diseases such as cancer. According to a World Health Organization (WHO) survey, chronic diseases accounted for roughly three-quarters of all deaths globally in 2020.

Furthermore, with increasing demand for data integrated imaging systems, the market is expected to expand at a faster pace. Hospitals and physicians all over the world are now using data integrated imaging systems to generate 3D images and get detailed information on a patient's medical history. Get a Free Sample Now@ https://www.reportsanddata.com/sample-enquiry-form/4025

Segments covered in the report:

For the purpose of this report, Reports and Data has segmented the global nuclear imaging equipment market on the basis of type, application, end user and region:

Type Outlook (Revenue, USD Billion; 2018 – 2028)

SPECT Imaging Systems

PET Imaging Systems

Planar Scintigraphy Imaging Systems

Application Outlook (Revenue, USD Billion; 2018 – 2028)

Neurology

Oncology

Cardiology

Others

End User Outlook (Revenue, USD Billion; 2018 – 2028)

Hospitals

Imaging Centers

Academic & Research Centers

Others

Some Key Highlight in the Report:

The Single Photon-Emission Computed     Tomography (SPECT) imaging systems accounted for the largest revenue share     in the global market in 2020 due to its lower cost as compared to hybrid     PET (Positron Emission Tomography) imaging systems.

The oncology segment isexpected to     register a significant CAGR during the forecast period due to rising     occurrence of tumors.

The hospitals segment accounted for the     largest revenue share among end user segments in the global market in 2020     due to large scale adoption of advanced nuclear imaging systems.

North America is expected to account for     largest revenue share over the forecast period due to rising adoption of     nuclear imaging technologies and introduction of new radiopharmaceuticals     for diagnosis.

Revenue from the Asia Pacific nuclear     imaging equipment market is projected to grow at a high rate.

Prominent     players in the market are Siemens     Healthineers, Koninklijke Philips N.V., GE Healthcare, Toshiba Medical     Systems Corporation, Neusoft Medical Systems Co., Ltd., Mediso Medical     Imaging Systems Co., Ltd., CMR Naviscan Corporation, Digirad Corporation,     SurgiEye GmbH, and Positron Corporation.

Ask for discount @ https://www.reportsanddata.com/discount-enquiry-form/4025

Regional Outlook (Revenue, USD Billion; 2018 – 2028)

·         North America

o    US

o    Canada

o    Mexico

·         Europe

o    Germany

o    UK

o    France

o    Italy

o    Spain

o    Russia

o    Rest of Europe

·         Asia Pacific

o    China

o    India

o    Japan

o    South Korea

o    Rest of Asia Pacific

·         Latin America

o    Brazil

o    Rest of Latin America

·         Middle East and Africa

o    Saudi Arabia

o    UAE

o    South Africa

o    Rest of Middle East & Africa

To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/nuclear-imaging-equipment-market

Thank you for reading our report. To know more about the customization of the report or further query about the report, please get in touch with us. Our team will ensure the report is well suited to your requirements.

[marketresearchtrendsblog]

Medical Image Analysis Software Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2020 - 2025

Medical image analysis software allows the practitioners to analyse and visualize the medical images. This analysed images further play vital role in treatment of patients. Image analysis software also provides the facility of remote accessing the analysis and data which is researched through internet. It makes it easy for healthcare professionals to monitor, diagnose and treat the disease.

Global Medical image analysis software market is anticipated to exceed US$ 4.50 billion in 2025 from USD 2.2 Billion in 2015. The revenue of this market is anticipated to increase at CAGR of 8.0% during the forecast period. North America is expected to lead the market by revenue accounting with largest share worldwide. Asia Pacific will grow with highest growth rate owing to increase in demand for medical image analysis software in healthcare centers.

Read more information about Global Market with Impact of Covid-19

To get Sample Copy of Business Report through this link: https://www.sdki.jp/sample-request-105944

Rapid growth in population rate and increasing rate of chronic diseases is a major driving factor. Rising demand of medical image analysis software in all the parts of countries of APAC region is triggering the growth of the market. The imaging software needs skilled professional with good experience in the field which is restraining factor where there is scarcity of these professionals. Increasing need of imaging of critical body parts owing to potential diseases is a driving factor.

The global medical image analysis software market by software type is segmented as integrated software and standalone software. According to its image types the market is further segmented in to 2D, 3D and 4D imaging. The market is further segmented according to its modality such as tomography, ultrasound imaging, radiography imaging and combined modalities. The application segment consists of orthopedic, dental, neurology, cardiology, oncology, obstetrics and gynaecology, mammography and urology and nephrology. The end-users of this market are hospitals, diagnostics centers and research centers. The market segments in terms of geographical regions include North America, Europe, Asia-Pacific and Rest of the World (ROW).

This report provides:

An overview of the global market for medical image analysis software and related technologies.

Analyses of global market trends, with data from 2016, estimates for 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2025.

Identifications of new market opportunities and targeted promotional plans for medical image analysis software market.

Discussion of research and development, and the demand for new products and new applications.

Comprehensive company profiles of major players in the industry.

REPORT SCOPE:

The scope of the report includes a detailed study of global and regional markets for various types of coatings with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include:

AGFA Healthcare

Aquilab

Carestream Health Inc.

Esaote S.p.A

GE Healthcare

Merge Healthcare Inc.

MIM Software Inc.

Philips Healthcare

Siemens Healthcare

Toshiba Medical Systems Corporation

Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.

The Medical image analysis software Market has been segmented as below:

by Software Type

Integrated Software

Standalone Software

by Image Type

2D Imaging

3D Imaging

4D Imaging

By Modality

Tomography

Computed Tomography (CT)

High-end Slice CT

Mid-end Slice CT

Low-end Slice CT

Magnetic Resonance Imaging (MRI)

Closed MRI Systems

Open MRI Systems

Positron Emission Tomography (PET)

Single-photon Emission Computed Tomography (SPECT)

Ultrasound Imaging

2D Imaging Systems

3D/4D Imaging Systems

Doppler Imaging

Radiographic Imaging

Combined Modalities

PET/CT

SPECT/CT

PET/MR

by Application

Orthopedic

Dental

Neurology

Cardiology

Oncology

Obstetrics and Gynecology

Mammography

Urology and Nephrology

by End-User

Hospitals

Diagnostic Centers

Research Centers

by Region

North America

Europe

Asia Pacific

Rest of the World (RoW)

Reasons to buy this Report:

Obtains the most up to date information available on all active and planned medical image analysis software industry globally.

Identify growth segments and opportunities in the industry.

Facilitate decision making on the basis of strong historic and forecast of medical image analysis software industry and unit capacity data.

Assess your competitor’s refining portfolio and its evolution.

Original Source of this content: https://www.sdki.jp/reports/medical-image-analysis-software-market/105944

For more information, Please contact us now:

Shibuya Data Count

Email: sales@sdki.jp

Tel: + 81 3 45720790

[uttam217]

Medical Imaging Equipment Market Industry Size, Global Trends, Growth, Opportunities, Market Share and Market Forecast - 2020 to 2027

The global medical imaging equipment market has been projected to grow at the CAGR of 5.5% market during 2020-2027. In 2019, the market has generated the revenue of $ 29.77 billion and now it has been expected to reach up to $ 48.17 billion in terms of revenue by 2025. The medical imaging equipment expected to show significant growth during the forecast period due to rising demand for medical imaging equipment owning to factors such as increasing number of diagnostic imaging centers, technological advancements in diagnostic imaging modalities and increasing incidence of orthopedic, dental and cardiac disorders would drive the growth of medical imaging market globally.

The report titled "Medical Imaging Equipment Market  - Global Trends, Market Share, Industry Size, Growth, Opportunities, and Forecast - 2020 – 2027" offers a holistic view of the Medical Imaging Equipment industry encompassing numerous stakeholders including raw material suppliers, providers, distributors, consumers and government agencies, among others. Furthermore, the report includes detailed quantitative and qualitative analysis of the global Medical Imaging Equipment market considering market history, product development, regional dynamics, competitive landscape, and key success factors (KSFs) in the industry.

Browse Full report on Global Medical Imaging Equipment Market report at https://www.researchcorridor.com/medical-imaging-equipments-market/

The report includes a deep-dive analysis of key countries including the U.S., Canada, the U.K., Germany, France, China, Japan, India, Australia, Mexico, Brazil and South Africa, among others. Thereby, the report identifies unique growth opportunities across the world based on trends occurring in various developed and developing economies.

Medical Imaging Equipment Market report summarizes the positive growth rate in upcoming years, and market size with competitive analysis. Our experts have analyzed the historical data to compare with the current market scenario to calculate the market growth in the coming years. The study provides an exhaustive report that includes an executive summary, scope, and forecast of the market.

The Medical Imaging Equipment Market Segmentation: By Product Type, 2018–2027 ($ Billion)

 Stationary X-Ray Devices

 Portable X-Ray Devices

 Cart/Trolley Based Ultrasound      Systems

 Compact/Portable Ultrasound      Systems

 Stationary CT Scanners

 Portable CT Scanners

 Closed MRI Equipment

 Open MRI Equipment

 Single Photon Emission      Computed Tomography (SPECT) Scanners

 Positron Emission Tomography      (PET) Scanners

By Technology, 2018–2027 ($ Billion)  

 X-ray Devices

 Analog X-ray Technology

 Digital Radiography (DR)

 Computed Radiography (CR)

 Ultrasound Imaging Technology

 3-D & 4-D Ultrasound      Imaging Technology

 Doppler Ultrasound Technology

 HIFU

 Low-Slice CT Scanners      (Medium-Slice CT Scanners (64 Slices)

 High-Slice Scanners (>64      Slices)

 High-Field MRI

 Mid-Field MRI

 Low-Field MRI

 Single Photon Emission      Computed Tomography (SPECT)

 Positron Emission Tomography      (PET)

By Geography, 2018-2027 ($Billion)

North America

Europe

Asia Pacific

Latin America (LATAM)

Middle East and Africa (MEA)

To know more about the study, make an inquiry before purchase @ https://www.researchcorridor.com/inquiry/?id=11093

List of Key companies:

Carestream Health, Inc.

Fonar Corporation

Fujifilm Holdings Corporation

GE Healthcare

Hitachi Medical Corporation

Hologic, Inc.

Philips Healthcare

Samsung Medison Co. Ltd.

Shimadzu Corporation

Siemens Healthcare

Toshiba Corporation

Key Questions Answered by Medical Imaging Equipment Market Report

Product popularity and adoption     based on various country-level dynamics

Regional presence and product     development for leading market participants

Market forecasts and trend     analysis based on ongoing investments and economic growth in key countries

Competitive landscape based on     revenue, product offerings, years of presence, number of employees and     market concentration, among others

number of employees and market     concentration, among others

To know more about this study, request a free sample report @ https://www.researchcorridor.com/request-sample/?id=11093

About Us: Research Corridor is a global market research firm. Our insightful analysis is focused on developed and emerging markets. We identify trends and forecast markets with a view to aid businesses identify market opportunities optimize strategies. Our expert’s team of analysts’ provides enterprises with strategic insights. Research Corridor works to help enterprises grow through strategic insights and actionable solutions. Feel free to contact us for any report customization at sales@researchcorridor.com .

Media Contact:

Company Name: Research Corridor Contact Person: Mr. Vijendra Singh Email: vijendrasingh@researchcorridor.com Contact no: +91 989-368-5690

Visit us: https://www.researchcorridor.com/

[reportsresearch]

Nuclear Medicine Imaging Market Outlooks 2020: Industry Analysis, Top Companies, Demand, Price and Forecast to 2027

Reports and Data’s latest study, titled ‘Global Nuclear Medicine Imaging Market’, presents a complete overview of the global Nuclear Medicine Imaging industry. The latest research report, specially curated by our team of skilled analysts, offers an all-encompassing examination of the market, with a major focus on the factors influencing the market growth in the upcoming years. This study performs a thorough qualitative and quantitative assessment of the global Nuclear Medicine Imaging Market. The report provides significant details on the highly competitive landscape of the Nuclear Medicine Imaging market, including the market shares of the key players and their business expansion strategies, to help businesses in this sector formulate relevant strategies to strengthen their market foothold.

To get a sample PDF copy of the report, visit @ https://www.reportsanddata.com/sample-enquiry-form/2415

The global Nuclear Medicine Imaging market, which was valued at USD XX Million in 2019, is now projected to garner up to USD XX Million by 2027, registering a robust CAGR of XX% during the estimated timeline. The study takes a closer look at the global market share, estimated growth rate, future market trends, entry barriers, as well as the key market drivers, restraints, challenges, and opportunities determining the global market growth. In addition, the research report entails full coverage of the ongoing impact of the COVID-19 outbreak on the Nuclear Medicine Imaging industry. The global health emergency has beleaguered this particular business domain, alongside affecting the global economy. Thus, the report assesses the present market scenario, besides analyzing the aftereffects of the pandemic in this business sector.

Competitive Terrain:

The global Nuclear Medicine Imaging market is intensely competitive owing to the presence of a large number of market contenders highly focused on the implementation of various strategic initiatives for business growth, such as mergers & acquisitions, partnerships and collaborations, joint ventures, brand promotions, new product launches, technological upgradation, and government and corporate deals. These companies are employing optimal business strategies to ensure financial flexibility and manufacturing process improvements. The growth rates, revenue figures, and gross profit margins of each of the market players have been enumerated in the report to help readers gain meaningful insights into the global Nuclear Medicine Imaging market mechanism.

The leading manufacturers profiled in the report are:

GE Healthcare, Lantheus Medical Imaging, Curium, Nordion, Novartis, Bayer, Eczacibasi-Monrol Nuclear Products, Cardinal Health, Bracco Imaging SPA, and Siemens Healthineers, among others.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2415

Global Nuclear Medicine Imaging Market Segmentation, based on geography:

·         North America (U.S., Canada)

·         Latin America (Chile, Brazil, Argentina, Rest of Latin America)

·         Europe (U.K., Italy, Germany, France, Rest of EU)

·         The Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

·         Asia-Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Type Outlook (Revenue, USD Million; 2017-2027)

Single-Photon     Emission Computed Tomography (SPECT) Systems

Positron     Emission Tomography (PET) Systems

Application Outlook (Revenue, USD Million; 2017-2027)

Oncology

Cardiology

Neurology

Thyroid

Others

End-User Outlook (Revenue, USD Million; 2017-2027)

Hospitals

Diagnostic     Centers

Research     Institutes

To know more about the report, visit @ https://www.reportsanddata.com/report-detail/nuclear-medicine-imaging-market

Key Questions & Answers Pertinent to the Global Nuclear Medicine Imaging Market:

·        Can new companies be added or profiled in the report as per our needs? Yes, new companies can be added or profiled in the report as per the requirements of our clients.  The final confirmation is to be provided by our research team, depending upon the market survey.

·        Which regional segments have been covered in the report? Can any specific country of interest be added to the Nuclear Medicine Imaging market report? The research report is currently focused on the following regions, including the United States, Europe, China, Asia Pacific, and other significant regions.

·        Can additional market segments be included in the report? Yes, additional market segments can be included in the latest report, depending upon the availability of ample market-related data and information.

The latest report provides the readers with a panoramic view of the Nuclear Medicine Imaging market on both global and regional levels. Besides offering the key statistical data and industry-verified facts, the report thoroughly investigates the present size, share, and volume of the Nuclear Medicine Imaging industry and forecasts future estimations for the market. It further analyzes the various growth prospects and threats that the market players might face in the near future.